DAXOR CORPORATION - CL
9.9439
25-11月-24 14:17:57
15 分の遅延
株式
+0.6597
+7.11%
本日の幅
9.0022 - 9.9899
ISIN
N/A
ソース
NASDAQ
-
Pilot Randomized Controlled Trial Validates Daxor BVA-100® Diagnostic for Heart Failure Patients
23 3 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
03 3 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
02 3 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
01 3 2023 07:00:02 提供 Nasdaq GlobeNewswire
-
Daxor Corporation Appoints Linda Cooper, Vice President Project Management
17 2 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Daxor Corporation Joins the Heart Failure Society of America (HFSA) as a Corporate Member
19 1 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2023 Critical Care Congress
13 1 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
03 1 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
17 11 2022 10:07:00 提供 Nasdaq GlobeNewswire
-
Daxor Corporation Announces Pricing of $2.0 million Underwritten Public Offering
15 11 2022 07:45:00 提供 Nasdaq GlobeNewswire
-
Daxor Corporation Announces Launch of Proposed Underwritten Public Offering
14 11 2022 16:03:51 提供 Nasdaq GlobeNewswire
-
10 11 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
03 11 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2022
31 10 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
05 10 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
04 10 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
03 10 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
03 10 2022 07:40:00 提供 Nasdaq GlobeNewswire
-
03 10 2022 07:00:01 提供 Nasdaq GlobeNewswire